Identification of intermediate-risk patients based on RVD and/or laboratory biomarkers was performed in three studies 10 , 13 , 19 with a trend towards reduced mortality of borderline significance.
← all excerpts
Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis.
1
—
—